| Jul-15-19 07:00AM | Altimmune Announces Closing of Acquisition of Spitfire Pharma, Inc. GlobeNewswire |
| Jul-12-19 02:55PM | Not just a vaccine company: How this Gaithersburg biotech CEO plans to grow the business American City Business Journals |
| Jul-09-19 04:45PM | Altimmune to acquire California company for up to $93M American City Business Journals +6.40% |
| 01:39PM | Germantown stem cell therapy company proposes $7M offering amid delisting threat American City Business Journals |
| 08:48AM | Altimmune To Acquire Spitfire Pharma For $5M, Add NASH Drug To Portfolio Benzinga |
| 07:15AM | Altimmune's stock soars after adding NASH candidate with purchase of Spitfire Pharma MarketWatch |
| 07:00AM | Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio GlobeNewswire |
| Jun-12-19 08:00AM | Altimmune Appoints Will Brown as Chief Financial Officer GlobeNewswire |
| Jun-10-19 08:00AM | Altimmune Announces Successful Pre-IND Meeting with FDA GlobeNewswire |
| Jun-05-19 08:00AM | Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs GlobeNewswire |
| May-14-19 04:15PM | Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update GlobeNewswire |
| May-08-19 08:00AM | Altimmune to Announce First Quarter 2019 Financial Results on May 15 GlobeNewswire |
| Apr-11-19 09:27AM | Altimmune To Present NasoVAX Phase 2 Data at the World Vaccine Congress in Washington, D.C. GlobeNewswire |
| Apr-02-19 06:30AM | Altimmune, Inc. to Host Earnings Call ACCESSWIRE -7.69% |
| Apr-01-19 04:20PM | Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update GlobeNewswire +12.07% |
| Mar-21-19 04:15PM | Altimmune to Announce Year End 2018 Financial Results on April 2 GlobeNewswire |
| Mar-19-19 12:21PM | Altimmune News: ALT Stock Skyrockets on Positive Flu Vaccine Data InvestorPlace +14.88% |
| 08:12AM | Altimmune's stock soars on heavy volume after positive trial data of flu vaccine candidate MarketWatch |
| 07:00AM | Altimmune Announces Positive Results from NasoVAX Extension Study GlobeNewswire |
| Mar-14-19 09:00AM | Altimmune to Participate at 31st Annual ROTH Conference GlobeNewswire |
| Mar-12-19 01:34PM | Altimmune Announces Closing of $14 Million Registered Direct Offering GlobeNewswire |
| Mar-08-19 09:29AM | Altimmune Announces $14 million Registered Direct Offering GlobeNewswire -36.56% |
| Jan-29-19 08:00AM | Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress in Vienna, Austria GlobeNewswire |
| Dec-14-18 07:00AM | Today's Research Reports on Trending Tickers: Sage Therapeutics and Altimmune ACCESSWIRE -10.79% |
| Dec-13-18 07:01AM | Altimmune Announces Clinical Program Updates and Plans for Pipeline Expansion GlobeNewswire -20.98% |
| Nov-30-18 06:06PM | Altimmune Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire +5.59% |
| Nov-27-18 09:00AM | Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer GlobeNewswire |
| Nov-23-18 07:00AM | Today's Research Reports on Trending Tickers: Altimmune and Johnson & Johnson ACCESSWIRE |
| Nov-13-18 04:50PM | Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire |
| Oct-26-18 11:29AM | Altimmune to Present at Dawson James Securities 4th Annual Small Cap Growth Conference GlobeNewswire |
| Oct-23-18 03:05PM | Gaithersburg biotech CEO to step down American City Business Journals |
| Oct-17-18 08:00AM | Todays Research Reports on Stocks to Watch: Altimmune and MannKind ACCESSWIRE |
| Oct-08-18 12:35PM | Why Altimmune Stock Is Sliding Lower Today InvestorPlace -31.77% |
| 09:00AM | Altimmune Announces $25 million Registered Direct Offering GlobeNewswire |
| Oct-03-18 08:00AM | Altimmune Closes on $16.9 Million in Funding GlobeNewswire |
| Oct-01-18 08:00AM | Todays Research Reports on Stocks to Watch: Aytu Bioscience and Altimmune ACCESSWIRE +13.18% |
| Sep-28-18 09:01AM | Altimmune Announces Pricing of $12 Million Underwritten Public Offering GlobeNewswire -49.89% |
| Sep-24-18 09:00AM | Altimmune Announces $4.9 million Registered Direct Offering of Common Stock GlobeNewswire -46.93% |
| 08:00AM | Altimmune Awarded $2.5 Million in Additional BARDA Funding to Support NasoShield Development GlobeNewswire |
| Sep-20-18 08:00AM | Todays Research Reports on Stocks to Watch: Molecular Templates and Altimmune ACCESSWIRE +59.36% |
| Sep-19-18 05:16PM | Why Altimmune Stock Is Skyrocketing Today InvestorPlace +285.48% |
| Sep-04-18 08:00AM | Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine GlobeNewswire |
| Aug-31-18 08:00AM | Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study GlobeNewswire |
| Aug-15-18 06:30AM | Altimmune, Inc. to Host Earnings Call ACCESSWIRE |
| Aug-14-18 04:01PM | Altimmune Announces Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire +9.39% |
| Aug-07-18 08:00AM | Altimmune to Announce Second Quarter 2018 Financial Results on August 15 GlobeNewswire |
| Jul-12-18 08:00AM | Altimmune Restructures Financing Agreement with Majority of the Remaining Series B Investors GlobeNewswire |
| Jul-10-18 08:00AM | Altimmune Appoints Mitchel Sayare as Executive Chairman of the Board, and Adds José Ochoa to Its Leadership Team as Chief Business Officer GlobeNewswire |
| Jun-22-18 04:15PM | Altimmune Restructures Financing Agreement GlobeNewswire |
| Jun-11-18 07:10AM | Stock Performance Review on Alder Biopharma and Three Other Biotech Stocks ACCESSWIRE -14.92% |
| Jun-05-18 06:45AM | U.S. hedge fund Hudson Bay to open London office - sources Reuters +5.62% |
| May-24-18 01:47PM | Does Altimmune Incs (NASDAQ:ALT) CEO Salary Reflect Performance? Simply Wall St. -7.77% |
| May-18-18 04:55PM | Gaithersburg biotech faces threat of stock delisting American City Business Journals |
| May-15-18 04:01PM | Altimmune Announces First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire |
| May-08-18 06:03PM | Who Are The Major Shareholders Of Altimmune Inc (NASDAQ:ALT)? Simply Wall St. |
| 08:00AM | Altimmune to Announce First Quarter 2018 Financial Results on May 16 GlobeNewswire |
| Apr-19-18 07:40AM | Free Research Report as ChemoCentryxs Quarterly Revenues Zoomed More than 1000%; Turned Profitable Y-O-Y ACCESSWIRE |
| Mar-28-18 04:44PM | Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update GlobeNewswire -13.04% |
| 11:10AM | Heres Whats Moving Esperion And Altimmune, Inc. Market Exclusive |
| Mar-27-18 08:00AM | Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection GlobeNewswire -17.86% |
| Mar-22-18 04:01PM | Altimmune to Participate at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire |
| Mar-20-18 04:01PM | Altimmune to Announce Year End 2017 Financial Results on March 29 GlobeNewswire |
| Mar-12-18 04:34PM | Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program GlobeNewswire |
| Mar-06-18 08:00AM | Altimmune to Participate at Two Investor Conferences in March GlobeNewswire -5.73% |
| Jan-23-18 08:00AM | Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S. GlobeNewswire |
| Jan-22-18 08:00AM | Altimmune to Participate at the Noble Capital 14th Annual Investor Conference GlobeNewswire |
| Jan-05-18 12:00PM | Should You Be Concerned About Altimmune Incs (NASDAQ:ALT) Investors? Simply Wall St. |
| Jan-03-18 08:00AM | Altimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of Directors GlobeNewswire |
| Dec-28-17 12:45PM | Is Altimmune Incs (NASDAQ:ALT) CEO Paid At A Competitive Rate? Simply Wall St. +8.17% |
| Dec-22-17 11:31AM | ETFs with exposure to Altimmune, Inc. : December 22, 2017 Capital Cube |
| Dec-21-17 04:01PM | Altimmune to Participate in the 10th Annual Biotech Showcase in San Francisco, January 8 10, 2018 GlobeNewswire |
| 08:00AM | Altimmune Announces Positive Initial Data from Its HepTcell Phase 1 Study GlobeNewswire |
| Dec-11-17 01:25PM | ETFs with exposure to Altimmune, Inc. : December 11, 2017 Capital Cube |
| 08:00AM | Altimmune Submits Investigational New Drug Application for NasoShield in Preparation for its Phase 1 Trial GlobeNewswire |
| Nov-30-17 01:15PM | ETFs with exposure to Altimmune, Inc. : November 30, 2017 Capital Cube -6.22% |
| Nov-21-17 08:00AM | Altimmune to Present at the 29th Annual Piper Jaffray Conference GlobeNewswire |
| Nov-20-17 11:31AM | ETFs with exposure to Altimmune, Inc. : November 20, 2017 Capital Cube |
| Nov-17-17 08:34AM | Altimmune, Inc. :ALT-US: Earnings Analysis: Q3, 2017 By the Numbers : November 17, 2017 Capital Cube |
| Nov-09-17 04:01PM | Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire |
| Nov-02-17 08:00AM | Altimmune to Announce Third Quarter 2017 Financial Results on November 9 GlobeNewswire |
| Oct-25-17 09:48AM | ETFs with exposure to Altimmune, Inc. : October 25, 2017 Capital Cube |
| Oct-10-17 10:58AM | ETFs with exposure to Altimmune, Inc. : October 10, 2017 Capital Cube |
| Sep-22-17 04:56PM | Whats Ahead For Altimmune Inc (ALT)? Simply Wall St. |
| Sep-20-17 08:00AM | Altimmune Announces its Phase 2 Flu Vaccine Trial with NasoVAX Open for Enrollment GlobeNewswire +5.42% |
| Sep-19-17 08:00AM | Altimmune to Provide Corporate Update at the Ladenburg Thalmann 3rd Annual Healthcare Conference GlobeNewswire |
| Sep-06-17 08:00AM | Altimmune to Provide Corporate Update at the Rodman & Renshaw Global Investment Conference GlobeNewswire |
| Aug-25-17 03:44PM | ETFs with exposure to Altimmune, Inc. : August 25, 2017 Capital Cube |
| Aug-23-17 07:11AM | Maryland biotech expanding into new Gaithersburg headquarters American City Business Journals |
| Aug-21-17 04:01PM | Altimmune Closes Series B Preferred Stock Offering GlobeNewswire |
| 08:00AM | Altimmune Submits Investigational New Drug Application for NasoVAX in Preparation for Phase 2 Trial GlobeNewswire |
| Aug-18-17 08:35PM | [$$] Investors Give Altimmune $14.7 Million Boost Following Reverse Merger The Wall Street Journal |
| Aug-17-17 10:09AM | Altimmune, Inc. :ALT-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017 Capital Cube -5.99% |
| 08:00AM | Altimmune Announces $14.7 Million Series B Preferred Stock Offering GlobeNewswire |
| Aug-10-17 12:25AM | Altimmune Announces Second Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire |
| Jul-31-17 08:00AM | Altimmune to Announce Second Quarter 2017 Financial Results on August 10 GlobeNewswire -6.32% |
| Jul-11-17 02:00PM | ETFs with exposure to Altimmune, Inc. : July 11, 2017 Capital Cube |
| Jun-19-17 08:00AM | Altimmune to Provide Corporate Update at the BIO International Convention GlobeNewswire |
| Jun-16-17 03:21PM | ETFs with exposure to Altimmune, Inc. : June 16, 2017 Capital Cube |
| May-16-17 08:00AM | Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer GlobeNewswire |
| May-11-17 10:45AM | Altimmune, Inc. :ALT-US: Earnings Analysis: Q1, 2017 By the Numbers : May 11, 2017 Capital Cube |
